CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0290
-0.0010 (-3.33%)
May 26, 2026, 11:55 AM EST
CV Sciences Revenue
CV Sciences had revenue of $3.20M in the quarter ending March 31, 2026, a decrease of -11.40%. This brings the company's revenue in the last twelve months to $13.38M, down -12.61% year-over-year. In the year 2025, CV Sciences had annual revenue of $13.79M, down -12.20%.
Revenue (ttm)
13.38M
Revenue Growth
-12.61%
P/S Ratio
0.45
Revenue / Employee
311.12K
Employees
44
Market Cap
6.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.79M | -1.92M | -12.20% |
| Dec 31, 2024 | 15.71M | -299.00K | -1.87% |
| Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
| Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
| Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eagle Pharmaceuticals | 257.55M |
| CordovaCann | 10.25M |
| Pure Harvest Corporate Group | 2.48M |
| Rafarma Pharmaceuticals | 133.33K |
| Cannabis Bioscience International Holdings | 123.63K |
| Kaya Holdings | 26.69K |
| Indo Global Exchange(s) PTE | 3.49K |
CV Sciences News
- 11 days ago - CV Sciences Earnings Call Transcript: Q1 2026 - Transcripts
- 11 days ago - CV Sciences Earnings release: Q1 2026 - Filings
- 11 days ago - CV Sciences Quarterly report: Q1 2026 - Filings
- 12 days ago - CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results - Accesswire
- 13 days ago - CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 - Accesswire
- 5 weeks ago - CV Sciences Proxy statement: Proxy filing - Filings
- 2 months ago - CV Sciences Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - CV Sciences Annual report: Q4 2025 - Filings